Crewe Advisors’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-29
Closed -$2.32K 469
2023
Q3
$2.32K Hold
29
﹤0.01% 327
2023
Q2
$2.34K Hold
29
﹤0.01% 526
2023
Q1
$3.52K Sell
29
-12
-29% -$1.63K ﹤0.01% 673
2022
Q4
$5.46K Sell
41
-68
-62% -$8.26K ﹤0.01% 654
2022
Q3
$12K Buy
109
+68
+166% +$8.7K ﹤0.01% 602
2022
Q2
$6K Buy
41
+12
+41% +$1.81K ﹤0.01% 713
2022
Q1
$5K Hold
29
﹤0.01% 391
2021
Q4
$5K Hold
29
﹤0.01% 352
2021
Q3
$5K Hold
29
﹤0.01% 298
2021
Q2
$5K Hold
29
﹤0.01% 328
2021
Q1
$4K Hold
29
﹤0.01% 381
2020
Q4
$3K Buy
+29
New +$2.9K ﹤0.01% 381

Other funds holding CNXC

Crewe Advisors's CNXC Position: Q4 2023 in Review

Crewe Advisors sold out of Concentrix (CNXC) in Q4 2023, closing a stake of 29 shares — an estimated $2.32K sold.

Crewe Advisors first reported a position in CNXC in Q4 2020 and held it in 12 quarters. The position peaked at $12K in Q3 2022. 311 funds tracked by Wall St. Rank hold CNXC as of Q4 2023.

  • Crewe Advisors reported no remaining Concentrix position as of Q4 2023 after selling out during the quarter.
  • Crewe Advisors sold 29 Concentrix shares in Q4 2023, an estimated $2.32K.
  • Crewe Advisors first reported a position in Concentrix in Q4 2020 and held it in 12 quarters.
  • Crewe Advisors's Concentrix position peaked at $12K in Q3 2022.
  • 311 funds tracked by Wall St. Rank held Concentrix as of Q4 2023.

Based on Crewe Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.